Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
AbbVie, accident, accidental, acute, adequacy, advisor, Aesthera, Africa, Alnylam, Andrea, April, Arena, ARIAD, Arizona, ATM, attend, attendance, attended, authentication, background, backup, Barbara, beam, belief, Beta, billed, Biographical, biography, Biomet, bionic, biopharmaceutical, Blazon, Bloom, booked, brain, breakthrough, brokered, Bronze, burn, CA, cadence, calendar, CAP, capable, cardiothoracic, career, Carlo, category, Celldex, CEO, Cerebrotech, chair, character, Chirac, Clawback, COBRA, Cogstate, Columbia, combat, comfort, commending, Compensia, complementary, concert, concurred, Congressman, contendere, contrast, Council, covenant, crime, culture, Cum, cyber, cybersecurity, CyperHeart, Czech, DDS, deferral, degradation, del, delegate, delegation, Deloitte, Diego, diminution, dissolved, Diversified, divisional, dollar, Dunnington, East, EDR, Eeva, email, embezzlement, embryo, encryption, Endocrine, expert, explanation, extortion, factual, faith, felony, fertilization, fifty, forgo, forgoing, formal, France, fraught, French, frontline, Gamma, Gan, gateway, GLP, graduated, guided, half, Harvard, Helena, hoc, honored, household, HR, HSMR, IA, IAM, imaging, India, indirect, intelligence, intraoperative, intrusion, Intuitive, involuntarily, IPS, irrespective, ISC, Isolaz, Israel, ISRG, Italy, iv, Ivonescimab, Knight, language, lapse, Laude, Legion, liaison, link, literacy, logging, lung, Magazine, Magna, Mahin, Mahkam, Mahshad, Maky, malware, mandate, Mare, MBA, meant, Medal, methodology, MFA, mind, mobile, molecule, Monte, moral, mother, multiplied, Napa, narrative, nearest, NEO, neurotechnology, Niv, nodule, nolo, nominee, nondisclosure, nsPDA, NYSE, Ospedale, outlining, overhang, oversee, overseeing, PAM, Pasteur, patch, Paul, peer, PEO, perception, phishing, Phoenix, photopneumatic, plea, posture, Prague, prepayment, privileged, Professor, Progyny, proportional, prorated, protocol, PSC, radiation, Radiosurgery, ransomware, readily, Reata, rebuilt, recipient, redefined, redundant, reelection, regular, relocation, remapping, renamed, reproduce, Republic, resorbed, Restated, RITA, robotic, Ron, rounded, San, Santa, Schiller, sector, session, SIEM, Sigma, Simplification, simulation, sister, soft, Solmetex, Solta, sooner, sophisticated, spanning, specialist, Spiezia, spot, spouse, Sr, St, StealthNet, Stefano, Strasbourg, subscribe, suspected, symptomatic, Takeda, tally, techology, telecommunication, Telly, terrorism, theft, therefrom, Thermage, thirty, thyroid, tightening, title, titled, tone, tool, tranche, transcatheter, transformed, transluminal, transmit, transmural, TSR, tumor, turpitude, ultrasound, unaffiliated, underrepresented, uterine, venture, war, warming, waste, web, Xlumena, ZBH, Zeltiq, Zimmer
Removed:
accessing, attestation, calculate, Clark, clinician, commencement, convertible, default, earliest, enactment, exchangeable, expose, golden, intention, irrevocably, Kenneth, lability, managed, nonbinding, owe, paper, prepare, reassessed, remeasured, responsive, resulted, RSU, simplified, simplifying, Treasury, unexercised, unrealized, withheld
Filing tables
Filing exhibits
- 10-K Annual report
- 10.26 Third Amendment to Employment Agreement, Between Kevin Danahy and Pulse Biosciences, Inc., Dated March 2024
- 10.27 Fourth Amendment to Employment Agreement, Between Darrin Uecker and Pulse Biosciences, Inc., Dated March 2024
- 21.1 Exhibit 21.1
- 23.1 Exhibit 23.1
- 31.1 Exhibit 31.1
- 32.1 Exhibit 32.1
- 97.1 Section 10D Clawback Policy
- Download Excel data file
- View Excel data file
Associated PLSE transcripts
PLSE similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-273944, 333-259330, 333-246346, 333-237577, 333-227974, 333-224800, 333-219104, and 333-219096 on Form S-3 and Registration Statement Nos. 333-271808, 333-264957, 333-256992, 333-254451, 333-237225, 333-229320, 333-222582, 333-221788, 333-218164, and 333-216897 on Form S-8 of our report dated March 28, 2024, relating to the financial statements of Pulse Biosciences, Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2023.
/s/ Deloitte & Touche LLP
San Jose, California